We quantified methylation within the promoter region of six genes: CRIP1, G0S2, MLH1, OPN3, S100 and TUBB2A. These genes have been implicated in cisplatin resistance of carcinomas other than HNSCC [11], [22], [23]. This evidence concerns the gene TUBB2A and head and neck squamous cell carcinoma.